Bias toward allopathic medicine in the research funding and publication of study results makes it difficult for physicians and others to find accurate data about the efficacy of non-Western, nonallopathic treatments.
Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.
Two physicians offer commentaries on the best course of action for a part-time janitor with no health insurance to receive the proper standard of care for his chronic recurrent prostatitis.
Physicians should take an occupational and environmental history of patients suffering from toxic chemical exposure in the workplace and advise them on ways to minimize further exposure to themselves and their families.